Reckitt Benckiser Group (LON:RB) received a GBX 5,300 ($69.25) price objective from equities research analysts at Royal Bank of Canada in a report released on Wednesday, Borsen Zeitung reports. The firm presently has a “sell” rating on the stock. Royal Bank of Canada’s target price suggests a potential downside of 19.84% from the stock’s previous close.

A number of other equities analysts have also weighed in on the company. JPMorgan Chase & Co. set a GBX 9,000 ($117.60) target price on Reckitt Benckiser Group and gave the stock a “buy” rating in a research report on Wednesday. Shore Capital reaffirmed an “under review” rating on shares of Reckitt Benckiser Group in a research report on Wednesday. Liberum Capital reaffirmed a “buy” rating on shares of Reckitt Benckiser Group in a research report on Wednesday. Barclays reaffirmed an “overweight” rating on shares of Reckitt Benckiser Group in a research report on Wednesday, June 5th. Finally, Credit Suisse Group reaffirmed an “underperform” rating on shares of Reckitt Benckiser Group in a research report on Thursday, May 9th. Three research analysts have rated the stock with a sell rating, four have issued a hold rating and eleven have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of GBX 7,154.12 ($93.48).

Shares of Reckitt Benckiser Group stock traded up GBX 217 ($2.84) on Wednesday, reaching GBX 6,612 ($86.40). 1,541,033 shares of the company’s stock were exchanged, compared to its average volume of 1,720,000. The company has a debt-to-equity ratio of 80.49, a quick ratio of 0.47 and a current ratio of 0.65. Reckitt Benckiser Group has a 52 week low of GBX 5,559 ($72.64) and a 52 week high of GBX 7,174 ($93.74). The stock has a market capitalization of $46.60 billion and a price-to-earnings ratio of 21.69.

In other Reckitt Benckiser Group news, insider Christopher Sinclair acquired 1,076 shares of Reckitt Benckiser Group stock in a transaction on Thursday, May 23rd. The stock was purchased at an average price of GBX 6,375 ($83.30) per share, for a total transaction of £68,595 ($89,631.52). Also, insider Andrew R. J. Bonfield acquired 146 shares of Reckitt Benckiser Group stock in a transaction on Tuesday, May 21st. The stock was acquired at an average price of GBX 6,290 ($82.19) per share, with a total value of £9,183.40 ($11,999.74).

About Reckitt Benckiser Group

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

Featured Story: Google Finance Portfolio

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.